Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data

被引：0
|
作者：
L. Cui
T. He
Y. Jiang
M. Li
O. Wang
R. Jiajue
Y. Chi
Q. Xu
X. Xing
W. Xia
机构：
[1] Chinese Academy of Medical Sciences,Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital
[2] Chinese Academy of Medical Sciences,Department of Hematology, Peking Union Medical College Hospital
[3] Beijing Jishuitan Hospital,Department of Orthopedics
来源：
Osteoporosis International | 2020年 / 31卷
关键词：
Chinese; cost-effectiveness; FRAX; Markov; osteoporosis; zoledronate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：307 / 316
页数：9
相关论文
共 50 条
  • [1] Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data
    Cui, L.
    He, T.
    Jiang, Y.
    Li, M.
    Wang, O.
    Jiajue, R.
    Chi, Y.
    Xu, Q.
    Xing, X.
    Xia, W.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (02) : 307 - 316
  • [2] Predicting the Intervention Threshold for Initiating Osteoporosis Treatment among Post-Menopausal Women in China: A Cost-Effectiveness Analysis Based on Real-World Data
    Cui, Lijia
    He, Tianhua
    Xia, Weibo
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 260 - 260
  • [3] PREDICTING THE INTERVENTION THRESHOLD FOR TREATING OSTEOPOROSIS AMONG POSTMENOPAUSAL WOMEN IN CHINA: A COST-EFFECTIVENESS ANALYSIS BASED ON FRAX
    Cui, L.
    He, T.
    Jiang, Y.
    Li, M.
    Wang, O.
    Xing, X.
    Xia, W.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S321 - S321
  • [4] Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
    Ben Johnson
    Edward Chia-Cheng Lai
    Huang-tz Ou
    Hong Li
    Björn Stollenwerk
    Archives of Osteoporosis, 2021, 16
  • [5] Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
    Johnson, Ben
    Lai, Edward Chia-Cheng
    Ou, Huang-tz
    Li, Hong
    Stollenwerk, Bjorn
    ARCHIVES OF OSTEOPOROSIS, 2021, 16 (01)
  • [6] COST-EFFECTIVENESS OF ABALOPARATIDE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Hiligsmann, M.
    Williams, S. A.
    Fitzpatrick, L. A.
    Reginster, J. -Y.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S50 - S51
  • [7] COST-EFFECTIVENESS OF ABALOPARATIDE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Hansson-Hedblom, A.
    Geale, K.
    Borgstrom, F.
    Johansson, H.
    Fitzpatrick, L.
    Kanis, J. A.
    VALUE IN HEALTH, 2018, 21 : S197 - S197
  • [8] Cost-effectiveness of antiosteoporosis strategies for postmenopausal women with osteoporosis in China
    Li, Na
    Zheng, Bin
    Liu, Maobai
    Zhou, Haimei
    Zhao, Lingfen
    Cai, Hongfu
    Huang, Jingze
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2019, 26 (08): : 906 - 914
  • [9] Cost-effectiveness of an adherence-enhancing intervention for gout based on real-world data
    Lin, Lydia Wenxin
    Teng, Gim Gee
    Lim, Anita Yee Nah
    Yoong, Joanne Su-Yin
    Zethraeus, Niklas
    Wee, Hwee-Lin
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (04) : 545 - 554
  • [10] Cost-effectiveness analysis of screening for osteoporosis in postmenopausal Japanese women
    Nagata-Kobayashi, S
    Shimbo, T
    Fukui, T
    JOURNAL OF BONE AND MINERAL METABOLISM, 2002, 20 (06) : 350 - 357
12345